Search Results
Benurestat 5 mg | 99.95%
TargetMol
AM-2394 25 mg | 99.58%
TargetMol

AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob/ob […]
More Information Supplier PageTriptophenolide 25 mg | 98.00%
TargetMol

Triptophenolide is a compound isolated from Tripterygium wilfordii Hook with anti-inflammatory activity.
More Information Supplier PageS107 2 mg | 99.63%
TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
More Information Supplier PageS107 25 mg | 99.63%
TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
More Information Supplier PageSHP099 hydrochloride 100 mg | 99.62%
TargetMol

SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageVU0155041 25 mg | 100.00%
TargetMol

VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat).
More Information Supplier PageKS176 2 mg | 99.55%
TargetMol

KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter, showing no inhibitory activity against P-gp or MRP1.
More Information Supplier PageURB602 25 mg | 99.64%
TargetMol

URB602 is a specific monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL (IC50: 28±4 μM) through a noncompetitive mechanism.
More Information Supplier Page